Drug Approval | October 20, 2021
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Second interchangeable biosimilar product approved by agency
Second interchangeable biosimilar product approved by agency
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
Since its inception, the company has either acquired or taken a majority stake in five companies
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
A total of 8308 stores are open across India and medicines are priced at affordable rates
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
Subscribe To Our Newsletter & Stay Updated
